20 June 2013
Keywords: epigenomics, 1st-qtr, income, declines, ag, german, firm
Article | 22 May 2006
Epigenomics AG, a German firm developing diagnostics on the basis of DNA methylation, says that, for the first three months ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 May 2006
15 May 2006
19 June 2013
© 2013 thepharmaletter.com